Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMA expects regulatory evaluation of advanced therapies to gather pace in EU

This article was originally published in Clinica

Executive Summary

The European Medicines Agency's Committee for Advanced Therapies says it expects to see more marketing authorisation applications for advanced therapy medicinal products being submitted for review over the next few years in view of the growing R&D pipeline in this sector. In 2013 alone, it expects to receive three to four new marketing applications.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099997

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel